TY - JOUR T1 - The Effect of Blood Cholinesterase Level on Health Symptoms among Chili Farmers in Sakon Nakhon Province, Thailand JF - medRxiv DO - 10.1101/2022.08.03.22278367 SP - 2022.08.03.22278367 AU - Ratchadaporn Pengpan AU - Ratanee Kammoolkon Y1 - 2022/01/01 UR - http://medrxiv.org/content/early/2022/08/04/2022.08.03.22278367.abstract N2 - BACKGROUND Farmers’ pesticide management practices are critical to restoring their health following exposure to pesticides. Pesticide safety management is poorly understood by the majority of farmers. If too many dangerous disinfectants are utilized, human health will be compromised. Therefore, this study aims to investigate the prevalence of health symptoms and their association with blood cholinesterase levels among chili farmers in Sakon Nakhon Province.METHODS A cross-sectional analytic study of 141 chili farmers was conducted. A health volunteer/research assistant collected data using a self-report questionnaire. A six-part questionnaire was provided. All subjects provided blood samples to be tested for acetylcholinesterase (AChE) inhibition by a medical technician in the laboratory. The Faculty of Medicine at Ramathibodi Hospital analysis report using a standard test kit for acetylcholinesterase (erythrocyte). Multivariate logistic regression models were used to predict the link between blood cholinesterase levels and health symptoms among chili farmers.RESULTS Farmers’ blood levels of the enzyme cholinesterase were at risk in 94 people (risk group) 66.7% and normal in 47 people 33.3% (normal group). A study discovered the prevalence of health symptoms and blood cholinesterase levels among chili farmers included nervous system of 53.2%, muscular system of 37.6%, respiratory system of 34.8%, skin system of 9.9% and gastrointestinal system of 1.4%. In addition, logistic regression models revealed a strong association between blood cholinesterase levels and health symptoms after adjustment. The cholinesterase levels at risk (<1.30 U/g) were at increased risk of developing health conditions in nervous system 2.2 times (AOR = 2.29; 95% CI = 1.10–4.76, p-value = 0.02), muscular system 3.5 times (AOR = 3.51; 95% CI = 1.49–8.27, p-value = 0.004), respiratory system 2.2 times (AOR = 2.28; 95% CI = 1.01–5.14, p-value = 0.04) and integumentary system 7.8 times (AOR = 7.87; 95% CI = 1.00–62.13. p-value = 0.05) of chili farmers with blood cholinesterase level normal level (≥1.30 U/g).CONCLUSION In this study, cholinesterase levels at risk (<1.30 U/g) were at risk of developing health conditions. Therefore, advocating for improved personal protection equipment and educating farmers about pesticide impact practices may also contribute to the reduction in chemical exposure.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was supported by Graduate Research Fellowships for publication in international academic journals, Kasetsart UniversityAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical Approval was obtained from Kasetsart University, Sakon Nakhon, and the accredited human ethics committee approved the study protocol of the research (Kucsc.HE-64-022).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript All data produced are available online at ER -